Delivery Order SPE2DB20D2104-SPE2DB23FT51Q
- Not listed
- This federal contract award, with a ceiling value of $1,441.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4559849024 units of Varenicline 1 mg tablets in 56-count packages. The award is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award is for the delivery of Varenicline 1 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The award, valued at $2,033.89, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This federal contract award is for the delivery of the medication varenicline 1 mg tablet, with a ceiling value of $13,835.98 and a period of performance through January 12, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA), a Defense agency. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award is for the delivery of Varenicline 1 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $1,481.74 and has an Ultimate Completion Date of February 9, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,460.62, is for the delivery of 4,562,766,401 units of Varenicline 1 mg tablets, a medication used to treat nicotine addiction. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award is for the delivery of 56 tablets of the pharmaceutical product Varenicline 0.5 mg. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,590.08 and a completion date of January 26, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Varenicline 1 mg tablets. The contract has a ceiling value of $10,118.90 and an ultimate completion date of March 24, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award is for the delivery of varenicline 1 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $2,209.82. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award for $3,179.20 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,812,168 units of the drug Varenicline 1 mg tablets. The contract has an ultimate completion date of April 7, 2022 and is structured as a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award, valued at $1,736.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of 56 tablets of the medication Varenicline 1 mg. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT51QDelivery Order
This federal contract award is for the delivery of 4,560,941,279 units of Varenicline 1 mg Tablets in 56-count packages. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a ceiling value of $2,858.47 and runs through May 16, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. As a major pharmaceutical distributor, Cencora, Inc. and its subsidiary Amerisourcebergen Drug Corp play a critical role in supplying essential medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/15/23 |